Work

Soluble Guanylate Cyclase Stimulators: a Novel Treatment Option for Heart Failure Associated with Cardiorenal Syndromes?

Year: 2016

Type: review

Source: Current Heart Failure Reports

DOI: 10.1007/s11897-016-0290-z

Authors: Ruth F. Dubin, Sanjiv J. Shah

Institutions: San Francisco VA Medical Center, University of California, San Francisco, Northwestern University

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: Transition from Risk Factors to Early HF: Prevalence, Pathogenesis, and Phenomics, Novel Echocardiographic Methods to Characterize Heart Failure in ESRD, Elucidating Pathways of Vascular Dysfunction and Myocardial Injury in ESRD, Determinants, Trajectories, and Consequences of Abnormal Cardiac Mechanics

OpenAlex ID: W2345266340

FWCI: 0.29

Cites: 49

Cited by: 19

Related to: 10